Glucocorticoids Pharmacology Flashcards
MA of Glucocorticoids
Inhibit gene transcription of COX-2 -> reduction of prostaglandin synthesis
Bind to cytoplasmic glucocorticosteroid receptor -> the complex inhibits transcription of many pro-inflammatory proteins
Reduces T-cell proliferation and
migration of inflammatory cells -> resulting in
impaired cell mediated immunity
Glucocorticoid effects
Anti-inflammatory
(redness, swelling, pain and heat)
Anti-allergic
Antirheumatic
Metabolic effects of glucocorticoids
Increased gluconeogenesis caused by:
inhibition of peripheral protein synthesis so that amino acids are available for glucose synthesis,
Decrease in glucose transport across membranes
reducing peripheral utilisation of glucose
Increased fatty acid release from fatty tissue and increased body fat deposited on face and trunk (moon faces, truncal obesity, buffalo hump)
New onset diabetes
Antigrowth hormone
Adrenal insufficiency
Metabolic effects of mineralocorticoids
Mimic aldosterone effects on the distal nephron :
Sodium retention
Potassium loss
Conn’s syndrome
Mineralocorticoid excess disease (aldosterone antagonists used to treat it –Spironolactone
and Eplerenone)
Hydrocortisone
Predominantly glucocorticoid with significant
mineralocorticoid activity
Absorption from variable , presystemic elimination
Metabolised in the liver -> decreased BA
Plasma half life 90mins (biological half life longer)
Prednisolone
Similar to hydrocortisone
Anti-inflammatory -four times more potent
Less active as a mineralocorticoid
Dexamethosone
Betamethasone
Powerful anti-inflammatory
No mineralocorticoid
effects
Mineralocorticoid examples
Aldosterone
Fludrocortisone
Aldosterone
1000 times more potent than hydrocortisone as mineralocorticoid
Acts on distal nephron – sodium and water retention, potassium loss
Fludrocortisone
500 times more potent than hydrocortisone as mineralocorticoid
Used as replacement therapy in patients with
adrenocortical insufficiency
Administered orally, undergoes presystemic elimination
Clinical Uses 1
Treatment of respiratory diseases: Asthma, Hayfever Sarcoidosis Extrinsic allergic alveolitis Fibosing alveolitis
Treatment of rheumatic and collagen disease: Rheumatoid Arthritis Polymyalgia rheumatica Systemic Lupus Erythromatosis Dermatomyositis
Clinical Uses 2
Treatment of skin disorders:
Eczema, psoriasis
Organ transplantation
Treatment of shock
Treatment of liver disease
Treatment of GIT disease:
Ulcerative colitis, Crohn’s
Treatment of nephrotic syndrome
Treatment of hypercalcaemia (sarcoidosis)
Treatment of brain oedema (inflammatory origin)
Replacement therapy in Addison’s disease
Treatment of congenital adrenal hyperplasia
Unwanted effects
Cushingoid physical appearance
Impaired resistance to infection
Delayed wound healing
Salt and water retention
Hypokalaemia
Hypertension
Hyperglycaemia
Osteoporosis
Peptic ulcer disease
Mental changes: anxiety, insomnia,elation, depression,
psychosis